MPT0B169, a New Antitubulin Agent, Inhibits BCR-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells
PLoS ONE - United States
doi 10.1371/journal.pone.0148093
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 27, 2016
Authors
Publisher
Public Library of Science (PLoS)